Loading...
Guided Therapeutics, Inc.
GTHP•PNK
Healthcare
Medical - Devices
$0.25
$0.04(18.10%)
Guided Therapeutics, Inc. (GTHP) Financial Performance & Income Statement Overview
Review Guided Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-92.86%
↓ 92.86%
Operating Income Growth
39.02%
↑ 39.02%
Net Income Growth
30.73%
↑ 30.73%
Operating Cash Flow Growth
35.91%
↑ 35.91%
Operating Margin
54075.00%
↑ 54075.00%
Gross Margin
-525.00%
↓ 525.00%
Net Profit Margin
66300.00%
↑ 66300.00%
ROE
77.98%
↑ 77.98%
ROIC
43.86%
↑ 43.86%
Guided Therapeutics, Inc. (GTHP) Income Statement & Financial Overview
Review Guided Therapeutics, Inc.'s (GTHP) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | -$4000.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | -$49000.00 | $0.00 | $24000.00 |
| Gross Profit | $0.00 | $45000.00 | $0.00 | -$24000.00 |
| Gross Profit Ratio | $0.00 | -$11.25 | $0.00 | |
| R&D Expenses | $74000.00 | $139000.00 | $111000.00 | $222000.00 |
| SG&A Expenses | $340000.00 | $415000.00 | $450000.00 | $433000.00 |
| Operating Expenses | $414000.00 | $554000.00 | $561000.00 | $655000.00 |
| Total Costs & Expenses | $0.00 | $529000.00 | $561000.00 | $655000.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$147000.00 | $134000.00 | $108000.00 | $75000.00 |
| Depreciation & Amortization | $0.00 | $24000.00 | $24000.00 | $24000.00 |
| EBITDA | -$414000.00 | -$494000.00 | -$522000.00 | -$610000.00 |
| EBITDA Ratio | $123.50 | |||
| Operating Income | -$414000.00 | -$533000.00 | -$561000.00 | -$655000.00 |
| Operating Income Ratio | $133.25 | |||
| Other Income/Expenses (Net) | -$13000.00 | -$119000.00 | -$93000.00 | -$54000.00 |
| Income Before Tax | -$427000.00 | -$652000.00 | -$654000.00 | -$709000.00 |
| Income Before Tax Ratio | $163.00 | |||
| Income Tax Expense | $36000.00 | $135000.00 | $0.00 | $0.00 |
| Net Income | -$463000.00 | -$826000.00 | -$654000.00 | -$709000.00 |
| Net Income Ratio | $206.50 | |||
| EPS | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Diluted EPS | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Weighted Avg Shares Outstanding | $68.29M | $57.34M | $57.04M | $55.99M |
| Weighted Avg Shares Outstanding (Diluted) | $68.29M | $57.34M | $57.04M | $55.99M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan